- Home
- TLSI vs KULR Comparison
TLSI vs KULR Comparison
Compare TLSI & KULR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- KULR
- Stock Information
- Founded
- TLSI 2010
- KULR 2013
- Country
- TLSI United States
- KULR United States
- Employees
- TLSI N/A
- KULR N/A
- Industry
- TLSI Medical Specialities
- KULR Electrical Products
- Sector
- TLSI Health Care
- KULR Technology
- Exchange
- TLSI Nasdaq
- KULR Nasdaq
- Market Cap
- TLSI 150.0M
- KULR 166.5M
- IPO Year
- TLSI N/A
- KULR N/A
- Fundamental
- Price
- TLSI $4.80
- KULR $4.52
- Analyst Decision
- TLSI Strong Buy
- KULR Strong Buy
- Analyst Count
- TLSI 5
- KULR 2
- Target Price
- TLSI $10.90
- KULR $40.00
- AVG Volume (30 Days)
- TLSI 95.6K
- KULR 1.4M
- Earning Date
- TLSI 11-13-2025
- KULR 11-12-2025
- Dividend Yield
- TLSI N/A
- KULR N/A
- EPS Growth
- TLSI N/A
- KULR N/A
- EPS
- TLSI N/A
- KULR N/A
- Revenue
- TLSI $35,990,000.00
- KULR $12,977,975.00
- Revenue This Year
- TLSI $56.79
- KULR $89.99
- Revenue Next Year
- TLSI $54.15
- KULR $97.50
- P/E Ratio
- TLSI N/A
- KULR N/A
- Revenue Growth
- TLSI 45.50
- KULR 35.81
- 52 Week Low
- TLSI $3.42
- KULR $2.02
- 52 Week High
- TLSI $5.88
- KULR $43.92
- Technical
- Relative Strength Index (RSI)
- TLSI 51.02
- KULR 41.00
- Support Level
- TLSI $4.41
- KULR $4.35
- Resistance Level
- TLSI $4.93
- KULR $4.65
- Average True Range (ATR)
- TLSI 0.28
- KULR 0.21
- MACD
- TLSI -0.05
- KULR 0.07
- Stochastic Oscillator
- TLSI 42.25
- KULR 56.67
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About KULR KULR Technology Group Inc.
KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems, artificial intelligence and Cloud computing, energy storage, 5G communication technologies, and other consumer and industrial devices.